Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Univec (UNVC) -- Ignore unavailable to you. Want to Upgrade?

To: Phil Cressman who wrote (134)	2/11/1998 2:33:00 AM
From: Yihchih Shern	Respond to of 181

I don't understand what you mean that you can't pick up some more cheap stock. Are you suggesting the stock is going to be higher? I am one of the guys that invested in this stock back duing the IPO time. I certainly hope the CEO is doing all he can to publicize the company and to make people aware of UNVC, for i hope the stock will truly reflect what the company has got one day. Heavy volume on the warrants today by the way. News forthcoming???

To: Phil Cressman who wrote (134)	2/12/1998 11:44:00 PM
From: r. peter Dale	Read Replies (1) \| Respond to of 181

Yeah my experience with Schoenfeld was similar. But this type of info is always far too subjective and self-serving to be of any value. Kinda like SI, eh? Peter Courtney - your suspicions about RXR/D2 are on target - one easy one: give retinoids to induce RXR to induce D2 upregulation; yeah right. Retinoids will induce massive upregulation of adhesion molecules and lead to a high amount of unwanted trafficing of stuff (such as, er, um, activated lymphocytes) in brain. But what do we know. Repeat verbatum:RXRs/retinoids cure every known (and unknown) neuropathology I gotta go.